| Not Yet Recruiting | Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study Methamphetamine Use Disorder | Phase 2 | 2026-05-01 |
| Recruiting | Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Onchocerciasis, Ascaris Lumbricoides Infection, Trichuris Trichiura; Infection | Phase 4 | 2025-08-04 |
| Active Not Recruiting | Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretr HIV Infections, Weight Gain | Phase 3 | 2024-12-16 |
| Not Yet Recruiting | PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitali Invasive Fungal Infections, Invasive Bacterial Infection, Injection Site Infection | — | 2024-03-01 |
| Unknown | National Prisons Hepatitis Education Project: Research Evaluation HCV | N/A | 2023-09-04 |
| Recruiting | Immunosuppression and COVID-19 Boosters COVID-19 | Phase 3 | 2023-07-21 |
| Recruiting | The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset Hepatitis C | — | 2023-01-25 |
| Completed | Evaluation of Hepatitis B Virus (HBV) DNA Test As Point of Care Tool Hepatitis B | — | 2022-11-17 |
| Unknown | A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to E Hepatitis C, Chronic | N/A | 2022-10-01 |
| Active Not Recruiting | Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Program Hepatitis C, Hepatitis C, Chronic | N/A | 2022-07-27 |
| Unknown | Australian Hepatitis and Risk Survey in Prisons Hepatitis C, Hepatitis B, HIV Infections | — | 2022-04-27 |
| Recruiting | The Australian HCV Point-of-Care Testing Program Hepatitis C | — | 2022-02-22 |
| Recruiting | Real World Assessment of People Living With Chronic Hepatitis B in Australia Hepatitis B | — | 2022-02-17 |
| Withdrawn | Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays Hepatitis B | — | 2022-01-01 |
| Recruiting | The National Australian HCV Point-of-Care Testing Program - Minimal Dataset Hepatitis C | — | 2021-12-01 |
| Active Not Recruiting | Efficacy Study of 4CMenB (Bexsero®) to Prevent Gonorrhoea Infection in Gay and Bisexual Men Neisseria Gonorrheae Infection | Phase 3 | 2021-07-08 |
| Completed | D²EFT Graphical Informed Consent HIV-1-infection | — | 2021-03-22 |
| Unknown | Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage Hepatitis C, Liver Inflammation, Liver Cirrhoses | N/A | 2021-02-12 |
| Withdrawn | Inflammation and Co-Infections in D²EFT HIV-infection/Aids, Human Herpesvirus 4 Infections, Cytomegalovirus Infections | Phase 4 | 2021-02-01 |
| Completed | COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings HIV-infection/Aids, Coronavirus Infection | — | 2020-08-12 |
| Unknown | Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) HIV-1-infection, Cancer, Primary Immune Deficiency Disorder | — | 2020-05-11 |
| Unknown | Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales COVID | — | 2020-05-06 |
| Unknown | Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvi Hepatitis C | Phase 4 | 2020-02-11 |
| Unknown | Impact of the Daily Doxycycline Pre-exposure Prophylaxis (PrEP) on the Incidence of Syphilis, Gonorrhoea and C STIs Prevention | — | 2019-12-17 |
| Completed | Body Composition Sub-study of the D2EFT Trial HIV Infections | Phase 4 | 2019-12-05 |
| Completed | Prisons Evaluation of a One-stop-shop InterVentiOn Hepatitis C | N/A | 2019-10-31 |
| Completed | A TEst and Treat Intervention aMong Current People Who Inject Drugs With HCV Attending Needle and Syringe PrOg Hepatitis C | N/A | 2019-09-10 |
| Completed | Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Rece Hepatitis C, Chronic | — | 2019-09-06 |
| Unknown | Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination Hepatitis C, Hepatitis, Liver Diseases | — | 2019-05-28 |
| Completed | Simplified Monitoring Myanmar SM2 Study Hepatitis C, Liver Cirrhoses, Liver Inflammation | N/A | 2019-01-22 |
| Completed | Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based Settings Hepatitis C, Chronic | — | 2018-08-17 |
| Unknown | ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Hepatitis C | N/A | 2018-05-28 |
| Completed | Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486 Myelodysplastic Syndromes, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia | Phase 2 | 2018-05-18 |
| Completed | The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar Helicobacter Pylori Infection | Phase 4 | 2018-01-01 |
| Active Not Recruiting | Age-related Clonal Haematopoiesis in an HIV Evaluation Cohort (ARCHIVE) HIV Infections, Aging | — | 2017-12-05 |
| Unknown | Dolutegravir and Darunavir Evaluation in Adults Failing Therapy HIV Infections | Phase 4 | 2017-11-23 |
| Completed | Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial HIV Prevention | Phase 3 | 2017-11-16 |
| Completed | Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients Hepatitis C, Chronic | Phase 3 | 2017-08-21 |
| Unknown | Study of Pomalidomide in Anal Cancer Precursors High Grade Squamous Intra-epithelial Lesion (HSIL) | Phase 2 | 2017-06-14 |
| Terminated | Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs Hepatitis C | Phase 4 | 2017-05-01 |
| Completed | Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Co Hepatitis C | Phase 3 | 2017-03-09 |
| Completed | A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Inf Hepatitis C, Chronic | Phase 4 | 2016-08-01 |
| Completed | Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P Hepatitis C, Acute | Phase 3 | 2016-06-01 |
| Completed | A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recen Hepatitis C | Phase 2 | 2016-03-16 |
| Completed | Expanded PrEP Implementation in Communities in NSW HIV, STI | Phase 3 | 2016-03-01 |
| Completed | Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints HIV | Phase 1 / Phase 2 | 2015-09-01 |
| Withdrawn | Impact of HCV Treatment on Neurocognitive Functions and Brain Metabolism Hepatitis C, Chronic | Phase 4 | 2015-07-01 |
| Completed | PrEP Demonstration Project (PRELUDE Study) HIV | Phase 4 | 2014-11-14 |
| Completed | Surveillance and Treatment of Prisoners With Hepatitis C Hepatitis C | Phase 4 | 2014-10-01 |
| Completed | DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) Hepatitis C | Phase 4 | 2014-10-01 |
| Terminated | Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Infected Patients HIV-1 Infection | — | 2014-09-01 |
| Unknown | Control and Elimination Within Australia of Hepatitis C From People Living With HIV Hepatitis C, HIV, HIV-HCV Coinfection | — | 2014-07-01 |
| Completed | DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C) Hepatitis C, Chronic | Phase 4 | 2013-01-01 |
| Completed | Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients Chronic Hepatitis C Infection | — | 2012-11-01 |
| Completed | Australian Trial in Acute Hepatitis C Recall Study Acute Hepatitis C | — | 2012-08-01 |
| Completed | A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3 Hepatitis C, Chronic | Phase 4 | 2012-06-01 |
| Completed | MARCH Central Nervous System Substudy HIV-1 Infection | — | 2012-06-01 |
| Completed | MARCH Vascular Endothelium Substudy Cardiovascular Disease | — | 2012-06-01 |
| Completed | MARCH Renal Substudy Proteinuria, HIV | Phase 4 | 2012-06-01 |
| Completed | The Neurocognitive Sub-study of Encore1 HIV | Phase 3 | 2012-01-01 |
| Completed | The Efavirenz (EFV) Central Nervous System Exposure Sub-study of Encore1 HIV Infection | Phase 3 | 2011-09-01 |
| Completed | The Intensive Pharmacokinetics Sub-study of Encore1 (ENCORE1-PK) HIV Infection | Phase 3 | 2011-09-01 |
| Completed | Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naï HIV Infections | Phase 3 | 2011-08-01 |
| Completed | Maraviroc Switch Collaborative Study HIV | Phase 4 | 2011-08-01 |
| Completed | Treatment of Recently Acquired Hepatitis C Virus Infection Acute Hepatitis C | Phase 4 | 2011-08-01 |
| Completed | Study of the Prevention of Anal Cancer Human Papillomavirus, Cancer | N/A | 2010-09-10 |
| Completed | A Study to Explore Reconstitution of Immunity in Patients With Advanced HIV-1-infection HIV Immune Restoration | — | 2010-09-01 |
| Completed | Bone and Body Comp: A Sub Study of the SECOND-LINE Study HIV | Phase 4 | 2010-02-01 |
| Completed | Pharmacokinetics of Lamivudine at Two Different Doses HIV Infections | Phase 1 / Phase 2 | 2009-12-01 |
| Completed | Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses. Acquired Immunodeficiency Syndrome | Phase 1 | 2009-10-01 |
| Completed | A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Sta HIV Infections | Phase 4 | 2009-09-01 |
| Completed | Raltegravir and Atazanavir Dosing Strategy Study HIV Infection | Phase 3 | 2009-07-01 |
| Completed | Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 HIV Infections | Phase 4 | 2009-03-01 |
| Completed | Hepatitis B Acceptability and Vaccination Incentive Trial Hepatitis B | N/A | 2008-09-01 |
| Completed | The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection HIV Infection | N/A | 2008-03-01 |
| Terminated | Thai Prophylactic HIV Vaccine Phase I Study HIV | Phase 1 / Phase 2 | 2007-08-01 |
| Completed | ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens Human Immunodeficiency Virus (HIV) | Phase 4 | 2007-02-01 |
| Completed | A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Ab HIV Infections | Phase 4 | 2005-12-01 |
| Terminated | Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatroph HIV-Associated Lipodystrophy, HIV Infections | Phase 4 | 2005-11-01 |
| Terminated | Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL- HIV Infections | Phase 3 | 2005-11-01 |
| Completed | A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-R HIV Infections | N/A | 2004-11-01 |
| Completed | Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Com HIV Infections, Dyslipidemias, Glucose Metabolism Disorders | Phase 4 | 2004-11-01 |
| Completed | Australian Trial in Acute Hepatitis C Hepatitis C | Phase 4 | 2004-07-01 |
| Completed | Tenofovir in HIV/HBV Coinfection HIV Infection, Hepatitis B Coinfection | Phase 4 | 2004-01-01 |
| Completed | HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) HIV-Associated Lipodystrophy Syndrome, Cardiovascular Disease | Phase 4 | 2003-02-01 |
| Completed | ITV Extension Study HIV | Phase 1 / Phase 2 | 2002-09-01 |
| Completed | Pravastatin for Hyperlipidaemia in HIV. HIV Infections, Lipid Metabolism, Glucose Metabolism | Phase 4 | 2001-07-01 |
| Completed | Can Resistance Enhance Selection of Treatment? (CREST) HIV Infection | N/A | 2001-03-01 |
| Withdrawn | A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Index Cases With Pr Pandemic Influenza | — | — |
| Withdrawn | A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Pandemic Influenza | — | — |
| Withdrawn | A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Rece Pandemic Influenza | — | — |